Recent Press Releases & News Mentions


March 9, 2023

Congressional Psychedelics Caucus

B.More Press Release

February 23, 2023

The 22 clinical trials that could make or break the future of the $100 billion psychedelics industry

Business Insider, Dr. Catherine Schuster-Bruce, Yeji Jesse Lee, Shayanne Gal, Annie Fu, and Alex Ford


November 6, 2022

Why aren’t there more ways to treat alcoholism?

Washington Post, Katherine Ellison

November 6, 2022

Carey Turnbull Wears Many Hats as a Donor and Investor

Lucid News, Marc Gunther

October 11, 2022

Magic mushrooms: An unlikely possible treatment for the rise in problem drinking

The San Antonio Report, Melissa Fletcher Stoeltje

September 20, 2022

B.More to Present at Psychedelic Capital

B.More Announcement

Additional B.More Phase 2A trial peer review published coverage


August 25, 2022

Psilocybin Therapy Sharply Reduces Excessive Drinking, Small Study Shows

New York Times. Andrew Jacobs

August 25, 2022

‘Magic mushroom’ psychedelic may help heavy drinkers quit

Associated Press. Carla K. Johnson

August 24, 2022

Can Magic Mushrooms Help Alcoholics? NYU Study Shows Promise

Bloomberg. Tiffany Karey

August 24, 2022

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows

NBC Nightly News. Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith

August 24, 2022

Hilft Psilocybin gegen Alkoholsucht?

Spiegel Gesundheit. Nina Weber

Older News and PR Articles



July 9, 2021

How Should We Do Drugs Now?

The New York Times. Michael Pollan

April 6, 2021

Is it Possible to Create an Ethical Psychedelics Company?

VICE NEWS. Shayla Love

March 22, 2021

NYU Raises $10M For Psychedelic Research and Training Center

LUCID NEWS. Colin Newton



April 13, 2019

A Psychedelic Renaissance

The Chronicle of Philanthropy. Marc Gunther



January, 2015

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

The Chronicle of Journal of Psychopharmacology 29(3). Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, PCR Barbosa and Rick J Strassman

January, 2015

Can psychedelic compounds play a part in drug dependence therapy?

The British journal of psychiatry. B. Sessa, M. Johnson


September 11, 2014

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Journal of Psychopharmacology. Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths

Stay informed of B. More
news and research

Just enter your email.

    Join us in building
    a better tomorrow

    You want to learn more about us?

    Join us in building a better tomorrow

    Skip to content